Hemophilia A Treatment Market [By Standard of Diagnosis (Mild Moderate & Severe), By Approved Drugs (Afstyla, Eloctate, Hemlibra, Kogenate FS, Kovaltry, Nuwiq & Obizur), By Care Delivery Model (Prophylaxis, On-demand therapy & Inhibitor therapy) and By Regions]: Market Estimate & Forecast, 2016 - 2022
- Published Date: Feb 2018
- Pages: 100
- Format: PDF
- Report ID: PM1107
- Base Year: 2017
- Historical Data: 2015-2016
血友病治疗市场规模、分享——工业上ry Report 2017-2022